Pharmaceutical Executive-10-29-2008

News Analysis
Pharmaceutical Executive

October 29, 2008

Affiris struck a deal with GlaxoSmithKline to develop two Alzheimer's treatments. As part of the agreement, GSK gains a fancy protein technology that could be a boon for future molecules.